Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications.
Caronna E, José Gallardo V, Alpuente A, Torres-Ferrus M, Sánchez-Mateo NM, Viguera-Romero J, López-Veloso AC, López-Bravo A, Gago-Veiga AB, Irimia Sieira P, Porta-Etessam J, Santos-Lasaosa S, Pozo-Rosich P; Spanish CGRP-COVID Study Group.
Caronna E, et al. Among authors: irimia sieira p.
Neurologia (Engl Ed). 2021 Mar 19;36(8):611-7. doi: 10.1016/j.nrl.2021.03.003. Online ahead of print.
Neurologia (Engl Ed). 2021.
PMID: 33832802
Free PMC article.